secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagonist Therapeutics, Inc (PTGX)
CIK:        0001377121
Form:       8-K
Filed at:   2024-09-20T23:59:59+00:00
Accession:  0001104659-24-101688
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Daniel N. Swisher Jr. resigns from Protagonist board; board reduced to six
--------------------------------------------------------------------------------

- Daniel N. Swisher Jr. resigned from the Board effective September 17, 2024; no disagreement with company operations.
- Swisher will continue as an advisor to the company under an advisory agreement.
- Sarah A. O'Dowd appointed to the Audit Committee effective September 19, 2024.
- Board size reduced from seven to six members concurrent with Swisher's resignation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1377121/000110465924101688/0001104659-24-101688-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1377121/000110465924101688/tm2424445d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-101688

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer